Many public and corporate groups are emphasising the need to increase funding in R&D for clinical diagnostic, forensic, proteomics, and genomes research. To get meaningful and reliable results, proper sample preparation is essential. Additionally, it is anticipated that over the projection period, increased research and development (R&D) spending by various government and private entities would lead to a rise in the use of improved sample preparation tools. For instance, the German Research Foundation (DFG) provided US$17.3 million in funding to four new sequencing labs in Germany in March 2018. Next-generation sequencing research will be carried out using the funds. With the use of its patented enzymatic technique, DNA Script hopes to innovate the production of DNA and RNA.
Global Sample Preparation Market is estimated to be valued at US$ 7,688.0 million in 2022 and is expected to exhibit a CAGR of 6.4% during the forecast period (2022-2030).
Leading Companies in the Sample Preparation Industry:
1. F. Hoffmann-La Roche AG
Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.
2. Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. In September, 2019 Bio-Rad Laboratories, Inc. announced the launch of the Science of Opioid Dependence Kit, offering high school and undergraduate educators a simple hands-on DNA electrophoresis activity to teach complex genetics in the context of the opioid crisis.
3. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. since 1956 offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. It has headquarters based in Waltham, Massachusetts. Thermo Fisher Scientific, the world leader in serving science, in the month of December. 2022 announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit.
